Diagnosis and treatment of cutaneous mastocytosis in children: Practical recommendations

American Journal of Clinical Dermatology

Volumn 12, Issue 4, 2011, Pages 259-270

  Castells, Mariana ^a   Metcalfe, Dean D ^b   Escribano, Luis ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c HOSPITAL VIRGEN DE LA SALUD   (Spain)

Author keywords

Antihistamines; Corticosteroids; Histamine H1 receptor antagonists; Histamine H2 receptor antagonists; Leukotriene receptor antagonists; Mast cell stabilisers; Mastocytosis; Psoralens; Skin disorders; Sodium cromoglicate; Urticaria pigmentosa

Indexed keywords

ANTIINFECTIVE AGENT; CETIRIZINE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DIPHENHYDRAMINE; HYDROXYZINE; PSORALEN; TRYPTASE; ZINC SULFATE;

BONE MARROW; CHILDHOOD DISEASE; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE COURSE; ENZYME BLOOD LEVEL; GENE MUTATION; HISTOPATHOLOGY; HUMAN; MAST CELL; ONCOGENE C KIT; PATHOGENESIS; PRIORITY JOURNAL; PUVA; REVIEW; SKIN CARE; SKIN DEFECT; URTICARIA PIGMENTOSA;

ANIMALS; BIOPSY; CHILD; DISEASE PROGRESSION; HUMANS; MAST CELLS; MASTOCYTOSIS, CUTANEOUS; URTICARIA PIGMENTOSA;

EID: 79958843169     PISSN: 11750561     EISSN: 11791888     Source Type: Journal    
DOI: 10.2165/11588890-000000000-00000     Document Type: Review

References (85)

1. Nettleship J, Tay W. Rare forms of urticaria. BMJ 1869; 2: 323-4
2. Sangster A. An anomalous mottled rash, accompanied by pruritus, factitious urticaria and pigmentation, 'urticaria pigmentosa (?)' [letter]. Trans Clin Soc London 1878; 11: 161
3. Ellis J. Urticaria pigmentosa: a report of a case of autopsy. Arch Pathol 1949; 48: 426-35
4. Degos R. Urticaria pigmentosa and other types of mastocytosis; attempted classification of cutaneous mastocytoses [in Spanish]. Actas Dermosifiliogr 1955; 46 (9): 759-85
5. Valent P, Horny HP, Escribano L, et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 2001; 25: 603-25 (Pubitemid 32506768)
6. Valent P, Akin C, Escribano L, et al. Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest 2007; 37 (6): 435-53 (Pubitemid 46817344)
7. Horny HP, Metcalfe DD, Bennet JM, et al. Mastocytosis. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC, 2008: 54-63
8. Kettelhut BV, Parker RI, Travis WD, et al. Hematopathology of the bone marrow in pediatric cutaneous mastocytosis: a study of 17 patients. AmJ Clin Pathol 1989; 91 (5): 558-62 (Pubitemid 19130281)
9. Kettelhut BV, Metcalfe DD. Pediatric mastocytosis. J Invest Dermatol 1991; 96 (3 Suppl.): 15S-8S
10. Soter NA. The skin in mastocytosis. J Invest Dermatol 1991; 96 (3 Suppl.): 32S-8S
11. Azana JM, Torrelo A, Mediero IG, et al. Urticaria pigmentosa: a review of 67 pediatric cases. Pediatr Dermatol 1994; 11 (2): 102-6 (Pubitemid 24174274)
12. Caplan RM. The natural course of urticaria pigmentosa: analysis and followup of 112 cases. Arch Dermatol 1963; 87: 146-57
13. Wolff K, Komar M, Petzelbauer P. Clinical and histopathological aspects of cutaneous mastocytosis. Leuk Res 2001; 25 (7): 519-28 (Pubitemid 32506758)
14. Hartmann K, Henz BM. Classification of cutaneous mastocytosis: a modified consensus proposal. Leuk Res 2002; 26 (5): 483-4
15. Worobec AS, Akin C, Scott LM, et al. Cytogenetic abnormalities and their lack of relationship to the Asp816Val c-kit mutation in the pathogenesis of mastocytosis. J Allergy Clin Immunol 1998; 102 (3): 523-4 (Pubitemid 28471518)
16. Sotlar K, Escribano L, Landt O, et al. One-step detection of c-kit point mutations using PNA-mediated PCR-clamping and hybridization probes. Am J Pathol 2003; 162 (3): 737-46 (Pubitemid 36237482)
17. Yanagihori H, Oyama N, Nakamura K, et al. c-kit mutations in patients with childhood-onset mastocytosis and genotype-phenotype correlation. J Mol Diagn 2005; 7 (2): 252-7 (Pubitemid 40668308)
18. Kasper CS, Tharp MD. Quantification of cutaneous mast cells using morphometric point counting and a conjugated avidin stain. JAmAcad Dermatol 1987; 16: 326-31 (Pubitemid 17013724)
19. Garriga MM, Friedman MM, Metcalfe DD. A survey of the number and distribution of mast cells in the skin of patients with mast cell disorders. J Allergy Clin Immunol 1988; 82 (3 Pt 1): 425-32
20. Gonzalez de Olano D, Alvarez-Twose I, Esteban-Lopez MI, et al. Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis. J Allergy Clin Immunol 2008; 121 (2): 519-26
21. Murphy M, Walsh D, Drumm B, et al. Bullous mastocytosis: a fatal outcome. Pediatr Dermatol 1999; 16 (6): 452-5 (Pubitemid 30030328)
22. Walker T, von Komorowski G, ScheurlenW, et al. Neonatal mastocytosis with pachydermic bullous skin without c-Kit 816 mutation. Dermatology 2006; 212 (1): 70-2 (Pubitemid 41779751)
23. Asboe-Hansen G, Clausen J. Mastocytosis (urticaria pigmentosa) with urinary excretion of hyaluronic acid and chondroitin sulfuric acid: changes induced by polymyxin B. Am J Med 1964; 36: 144-50
24. Macpherson JL, Kemp A, Rogers M, et al. Occurrence of platelet-activating factor (PAF) and an endogenous inhibitor of platelet aggregation in diffuse cutaneous mastocytosis. Clin Exp Immunol 1989; 77: 391-6 (Pubitemid 19234388)
25. Van Gysel D, Oranje AP, Vermeiden I, et al. Value of urinary N-methylhistamine measurements in childhood mastocytosis. J Am Acad Dermatol 1996; 35 (4): 556-8 (Pubitemid 26427056)
26. Brockow K, Akin C, Huber M, et al. Assessment of the extent of cutaneous involvement in children and adults with mastocytosis: relationship to symptomatology, tryptase levels, and bone marrow pathology. J Am Acad Dermatol 2003; 48 (4): 508-16 (Pubitemid 36397011)
27. Heide R, van Doorn K, Mulder PG, et al. Serum tryptase and SCORMA (SCORing MAstocytosis) Index as disease severity parameters in childhood and adult cutaneous mastocytosis. Clin Exp Dermatol 2009 Jun; 34 (4): 462-8
28. Hannaford R, Rogers M. Presentation of cutaneous mastocytosis in 173 children. Australas J Dermatol 2001; 42 (1): 15-21 (Pubitemid 32165280)
29. Akoglu G, Erkin G, Cakir B, et al. Cutaneous mastocytosis: demographic aspects and clinical features of 55 patients. J Eur Acad Dermatol Venereol 2006; 20 (8): 969-73
30. Kiszewski AE, Duran-Mckinster C, Orozco-Covarrubias L, et al. Cutaneous mastocytosis in children: a clinical analysis of 71 cases. J Eur Acad Dermatol Venereol 2004; 18 (3): 285-90 (Pubitemid 38618323)
31. Ben-Amitai D, Metzker A, Cohen HA. Pediatric cutaneous mastocytosis: a review of 180 patients. Isr Med Assoc J 2005; 7 (5): 320-2 (Pubitemid 40668155)
32. Worobec AS, Metcalfe DD. Mastocytosis: current treatment concepts. Int Arch Allergy Immunol 2002; 127 (2): 153-5 (Pubitemid 34264206)
33. Worobec AS. Treatment of systemic mast cell disorders. Hematol Oncol Clin North Am 2000; 14 (3): 659-87 (Pubitemid 30436939)
34. Apter AJ, Rothe MJ. Referred for management of mastocytosis. Ann Allergy Asthma Immunol 1997; 79 (1): 21-6 (Pubitemid 27318016)
35. Golkar L, Bernhard JD. Mastocytosis. Lancet 1997; 349 (9062): 1379-85 (Pubitemid 27197549)
36. Kurosawa M, Amano H, Kanbe N, et al. Heterogeneity of mast cells in astocytosis and inhibitory effect of ketotifen and ranitidine on indolent systemic mastocytosis. J Allergy Clin Immunol 1997; 100 (6 Pt 2): S25-32
37. Longley J, Duffy TP, Kohn S. The mast cell and mast cell disease. J Am Acad Dermatol 1995; 32: 545-61
38. Friedman BS, Santiago ML, Berkebile C, et al. Comparison of azelastine and chlorpheniramine in the treatment of mastocytosis. J Allergy Clin Immunol 1993; 92: 520-6 (Pubitemid 23317077)
39. Austen KF. Systemic mastocytosis. N Engl J Med 1992; 326: 639-40
40. Metcalfe DD. The treatment of mastocytosis: an overview. J Invest Dermatol 1991; 96 (3 Suppl.): 55S-6S
41. Welch EA, Alper JC, Bogaars H, et al. Treatment of bullous mastocytosis with disodium cromoglycate. J Am Acad Dermatol 1983; 9 (3): 349-53 (Pubitemid 13051874)
42. Escribano L, García-Belmonte D, Hernández-Gonzá lez A, et al. Successful management of a case of diffuse cutaneous mastocytosis with recurrent anaphylactoid episodes and hypertension [abstract]. J Allergy Clin Immunol 2004; 113 (2): S335
43. Bianchine PJ, Metcalfe DD. Systemic mastocytosis. In: Kaplan AP, editor. Allergy. Philadelphia (PA): WB Saunders, 1997: 854-60
44. Marone G, Spadaro G, Granata F, et al. Treatment of mastocytosis: pharmacologic basis and current concepts. Leuk Res 2001; 25 (7): 583-94 (Pubitemid 32506766)
45. Metcalfe DD. Clinical advances in mastocytosis: an interdisciplinary roundtable discussion. J Invest Dermatol 1991; 96 Suppl.: 1S-65S
46. Zhang MQ. Chemistry underlying the cardiotoxicity of antihistamines. Curr Med Chem 1997; 4 (3): 171-84
47. Fenske NA, Lober CW, Pautler SE. Congenital bullous urticaria pigmentosa: treatment with concomitant use of H1- and H2-receptor antagonists. Arch Dermatol 1985; 121 (1): 115-8 (Pubitemid 16225035)
48. Frieri M, Alling DW,Metcalfe DD. Comparison of the therapeutic efficacy of cromolyn sodium with that of combined chlorpheniramine and cimetidine in systemic mastocytosis: results of a double-blind clinical trial. Am JMed 1985; 78 (1): 9-14 (Pubitemid 15159611)
49. Gasior-Chrzan B, Falk ES. Systemic mastocytosis treated with histamine H1 and H2 receptor antagonists. Dermatologica 1992; 184: 149-52
50. Hirschowitz BI,Groarke JF. Effect of cimetidine on gastric hypersecretion and diarrhea in systemic mastocytosis. Ann Intern Med 1979; 90 (5): 769-71 (Pubitemid 9182462)
51. Johnson GJ, Silvis SE, Roitman B, et al. Long-term treatment of systemic mastocytosis with histamine H2 receptor antagonists. Am J Gastroenterol 1980; 74 (6): 485-9 (Pubitemid 11146847)
52. Berg MJ, Bernhard H, Schentag JJ. Cimetidine in systemic mastocytosis. Drug Intell Clin Pharm 1981; 15 (3): 180-3
53. Collen MJ, Howard JM, McArthur KE, et al. Comparison of ranitidine and cimetidine in the treatment of gastric hypersecretion. Ann InternMed 1984; 100 (1): 52-8 (Pubitemid 14219129)
54. Debeuckelaere S, Schoors DF, Devis G. Systemic mast cell disease: a review of the literature with special focus on the gastrointestinal manifestations. Acta Clin Belg 1991; 46 (4): 226-32
55. Goto T, Sakashita H, Murakami K, et al. Novel histamine H3 receptor antagonists: synthesis and evaluation of formamidine and S-methylisothiourea derivatives. Chem Pharm Bull (Tokyo) 1997; 45 (2): 305-11 (Pubitemid 27131855)
56. Van Cauwenberge PB, De Moor SEG. Physiopathology of H3-receptors and pharmacology of betahistine. Acta Otolaryngol (Stockh) 1997; 117: 43-6
57. Linney ID, Buck IM,Harper EA, et al. Design, synthesis, and structure-activity relationships of novel non-imidazole histamine H3 receptor antagonists. J Med Chem 2000; 43 (12): 2362-70 (Pubitemid 30431934)
58. Blandizzi C, Colucci R, Tognetti M, et al. H3 receptor-mediated inhibition of intestinal acetylcholine release: pharmacological characterization of signal transduction pathways. Naunyn Schmiedebergs Arch Pharmacol 2001; 363 (2): 193-202 (Pubitemid 32200327)
59. Dolovich J, Punthakee ND, MacMillan AB, et al. Systemic mastocytosis: control of lifelong diarrhea by ingested disodium cromoglycate. Can Med Assoc J 1974; 111 (7): 684-5
60. Soter NA, Austen KF, Wasserman SI. Oral disodium cromoglycate in the treatment of systemic mastocytosis. N Engl J Med 1979; 301: 465-9 (Pubitemid 10219950)
61. Horan RF, Sheffer AL, Austen KF. Cromolyn sodium in the management of systemic mastocytosis. J Allergy Clin Immunol 1990; 85 (5): 852-5 (Pubitemid 20173119)
62. Haustein UF, BedriM. Bullous mastocytosis in a child [in German]. Hautarzt 1997; 48 (2): 127-9
63. Leaf FA, Jaecks EP, Rodriguez DR. Bullous urticaria pigmentosa. Cutis 1996; 58 (5): 358-60
64. Mackey S, Pride HB, Tyler WB. Diffuse cutaneous mastocytosis: treatment with oral psoralen plus UV-A. Arch Dermatol 1996; 132 (12): 1429-30 (Pubitemid 26424540)
65. Smith ML, Orton PW, Chu H, et al. Photochemotherapy of dominant, diffuse, cutaneous mastocytosis. Pediatr Dermatol 1990; 7 (4): 251-5
66. van Furth AM, van de Rhee HJ, van Zwieten PH, et al. Congenital bullous urticaria pigmentosa [in Dutch]. Tijdschr Kindergeneeskd 1993; 61 (2): 58-62
67. Abdullah AN, Keczkes K. Cutaneous and ocular side-effects of PUVA photochemotherapy: a 10-year follow-up study. Clin Exp Dermatol 1989; 14 (6): 421-4 (Pubitemid 19278987)
68. Stern RS, Nichols KT, Vakeva LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA): the PUVA Follow-Up Study. N Engl J Med 1997; 336 (15): 1041-5 (Pubitemid 27163855)
69. WallenfangK, Stadler R. Association betweenUVA1 and PUVAbath therapy and development of malignant melanoma [in German]. Hautarzt 2001; 52 (8): 705-7 (Pubitemid 32757702)
70. Greenblatt EP, Chen L. Urticaria pigmentosa: an anesthetic challenge. J Clin Anesth 1990; 2: 108-15
71. Stellato C, De Paulis A, Cirillo R, et al. Heterogeneity of human mast cells and basophils in response to muscle relaxants. Anesthesiology 1991; 74: 1078-86
72. Scott JrHW, Parris WC, Sandidge PC, et al. Hazards in operative management of patients with systemic mastocytosis. Ann Surg 1983; 197 (5): 507-14 (Pubitemid 13080039)
73. Hosking MP, Warner MA. Sudden intraoperative hypotension in a patient with asymptomatic urticaria pigmentosa. Anesth Analg 1987; 66 (4): 344-6 (Pubitemid 17060815)
74. Lerno G, Slaats G, Coenen E, et al. Anaesthetic management of systemic mastocytosis. Br J Anaesth 1990; 65 (2): 254-7 (Pubitemid 20244580)
75. Borgeat A, Ruetsch YA. Anesthesia in a patient with malignant systemic mastocytosis using a total intravenous anesthetic technique. Anesth Analg 1998; 86 (2): 442-4 (Pubitemid 28079509)
76. Carter MC, Uzzaman A, Scott LM, et al. Pediatric mastocytosis: routine anesthetic management for a complex disease. Anesth Analg 2008; 107 (2): 422-7
77. Coleman MA, Liberthson RR, Crone RK, et al. General anesthesia in a child with urticaria pigmentosa. Anesth Analg 1980; 59 (9): 704-6
78. James PD, Krafchik BR, Johnston AE. Cutaneous mastocytosis in children: anaesthetic considerations. Can J Anaesth 1987; 34 (5): 522-4 (Pubitemid 18022312)
79. Brodier C, Guyot E, Palot M, et al. Anesthesia of a child with a cutaneous mastocytosis [in French]. Cah Anesthesiol 1993; 41 (1): 77-9
80. Tirel O, Chaumont A, Ecoffey C. Circulatory arrest in the course of nesthesia for a child with mastocytosis [in French]. Ann Fr Anesth Reanim 2001; 20 (10): 874-5 (Pubitemid 34016317)
81. Nelson LP, Savelli-Castillo I. Dental management of a pediatric patient with mastocytosis: a case report. Pediatr Dent 2002; 24 (4): 343-6
82. Lorenz W. Histamine release in man. Agents Actions 1975; 5 (5): 402-16
83. Booij LH, Krieg N, Crul JF. Intradermal histamine releasing effect caused by Org-NC 45: a comparison with pancuronium, metocurine and d-tubocurarine. Acta Anaesthesiol Scand 1980; 24 (5): 393-4 (Pubitemid 10004450)
84. Flacke JW, Flacke WE, Bloor BC, et al. Histamine release by four narcotics: a double-blind study in humans. Anesth Analg 1987; 66 (8): 723-30
85. Fisher MM, Baldo BA. Mast cell tryptase in anaesthetic anaphylactoid reactions. Br J Anaesth 1998; 80 (1): 26-9 (Pubitemid 28029719)